Keyphrases
Tuberculous Meningitis
75%
Molecular Imaging
44%
Central Nervous System
31%
Positron Emission Tomography
31%
Tuberculosis
28%
Central Nervous System Infections
26%
Brain Development
22%
COVID-19
20%
Pharmacokinetics
17%
Custody
17%
Translational Research
17%
Tuberculosis Treatment
17%
Pretomanid
15%
Mycobacterium Tuberculosis (M. tb)
15%
Tuberculosis Meningitis
13%
Antibiotic Exposure
13%
Pediatric
12%
Children at Risk
11%
Knowledge Gaps
11%
Young children
11%
Matrix Metalloproteinases
11%
Vulnerability
11%
Intracerebral Inflammation
11%
Antibiotics
10%
Clinical Translation
10%
Spatially Heterogeneous
10%
Dynamic Positron Emission Tomography
10%
Cerebrospinal Fluid
9%
Brain Tissue
9%
Mass Spectrometry
9%
Mouse Model
9%
High Titer
8%
MRSA Infection
8%
Preclinical Tool
8%
Systemic Immune Response
8%
Acute Brain Injury
8%
In Situ
8%
Receptor Subunits
8%
Human Studies
8%
Infectious Process
8%
Neuroimaging Findings
8%
Standardized Guidelines
8%
Young Adult Patients
8%
Diabetic Foot
8%
Bacterial Infection
8%
Organ Dysfunction
8%
Delamanid
8%
Mass Lesion
8%
Synapse
8%
CoV-2
8%
Medicine and Dentistry
Tuberculous Meningitis
76%
Infection
41%
Molecular Imaging
35%
Disease
29%
Tuberculosis Treatment
27%
Positron Emission Tomography
20%
Pediatrics
19%
Translational Research
17%
COVID-19
17%
Diagnosis
15%
Toddlers
15%
Human Immunodeficiency Virus
11%
Mycobacterium Tuberculosis
11%
Adolescent
11%
Cohort Effect
11%
Supportive Care
11%
Intensive Care
11%
Central Nervous System
11%
Magnetic Resonance Imaging
10%
Brain Injury
9%
Illicit Drug
8%
Diabetic Foot
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Carbon 11
8%
Meningitis
8%
Bacterial Infection
8%
Microglia
8%
Drug Abuse
8%
Checklist
8%
Resuscitation
8%
Staphylococcus Aureus
8%
Severe Acute Respiratory Syndrome
8%
Coronavirinae
8%
4 Aminobenzoic Acid
8%
Radioactive Tracer
8%
Matrix Metalloproteinase
8%
Central Nervous System Infection
8%
Methicillin Resistant Staphylococcus Aureus Infection
8%
Tuberculoma
8%
Central Nervous System Tuberculosis
8%
Treatment Response
7%
Early Diagnosis
6%
Pathogen
5%
Macrophage
5%
Immunohistochemistry
5%
Abscess
5%
Treatment Duration
5%
Cerebrospinal Fluid
5%
Clinical Trial
5%
Clinician
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tuberculous Meningitis
100%
Infection
29%
Disease
29%
Rifampicin
27%
Mycobacterium Tuberculosis
27%
Meningitis
23%
Tuberculoma
20%
Abscess
17%
Pretomanid
17%
Rabbit Model
16%
HIV
15%
Central Nervous System Tuberculosis
14%
Fluorine 18
14%
Inflammation
14%
Pharmacokinetics
13%
Linezolid
12%
Biodistribution
11%
Carbon 11
11%
Clinical Trial
11%
Prevalence
9%
Mouse Model
9%
Severe Acute Respiratory Syndrome
8%
Human Study
8%
Coronavirinae
8%
Delamanid
8%
Matrix Metalloproteinase
8%
Intracranial Tuberculoma
8%
Combination Therapy
8%
Lung Lesion
8%
Antiinfective Agent
8%
Lung Tuberculosis
7%
Lipidome
7%
Leporidae
5%
Antibiotics
5%
Pharmacokinetic Modeling
5%
Oxysterol
5%
Matrix-Assisted Laser Desorption/Ionization
5%
Bacilli
5%
